J Pediatr Genet 2019; 08(02): 058-062
DOI: 10.1055/s-0039-1684008
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Ataxia with Oculomotor Apraxia Type 4 with PNKP Common “Portuguese” and Novel Mutations in Two Belarusian Families

Galina E. Rudenskaya
1   Department of Genetic Counseling, Research Centre for Medical Genetics, Moscow, Russian Federation
,
Andrey V. Marakhonov
1   Department of Genetic Counseling, Research Centre for Medical Genetics, Moscow, Russian Federation
,
Olga A. Shchagina
1   Department of Genetic Counseling, Research Centre for Medical Genetics, Moscow, Russian Federation
,
Ekaterina R. Lozier
2   Independent Clinical Bioinformatics Laboratory, Moscow, Russian Federation
,
Elena L. Dadali
1   Department of Genetic Counseling, Research Centre for Medical Genetics, Moscow, Russian Federation
,
Irina A. Akimova
1   Department of Genetic Counseling, Research Centre for Medical Genetics, Moscow, Russian Federation
,
Nika V. Petrova
1   Department of Genetic Counseling, Research Centre for Medical Genetics, Moscow, Russian Federation
,
Fedor A. Konovalov
2   Independent Clinical Bioinformatics Laboratory, Moscow, Russian Federation
› Author Affiliations
Further Information

Publication History

25 December 2018

21 February 2019

Publication Date:
27 March 2019 (online)

Abstract

Ataxia with oculomotor apraxia type 4 (AOA4) is a rare autosomal recessive, PNKP-related disorder delineated in 2015 in Portugal. We diagnosed AOA4 by next generation sequencing (NGS) followed by Sanger's sequencing in three boys from two unrelated Belarusian families. In both families, one of the heterozygous PNKP mutations was c.1123G>T, common in Portuguese patients; biallelic mutations, c.1270_1283dup14 and c.1029+2T>C, respectively, were novel. These are the first reported AOA4 Slavic cases and the first with a “Portuguese” PNKP mutation outside Portugal. Distinction in two brothers was microcephaly but their disease was not severe in contrast to PNKP-related “microcephaly, seizures, and developmental delay” and reported cases with features of both phenotypes.

Authors' Contribution

Authors G.E.R. and A.V.M. have designed the study; authors G.E.R., O.A.S., E.L.D., I.A.A., N.V.P. have collected data for the study; authors G.E.R., A.V.M., O.A.S., E.R.L., F.A.K. have done data analysis; and authors G.E.R., A.V.M. have prepared the manuscript.


Supplementary Material

 
  • References

  • 1 Bras J, Alonso I, Barbot C. , et al. Mutations in PNKP cause recessive ataxia with oculomotor apraxia type 4. Am J Hum Genet 2015; 96 (03) 474-479
  • 2 Shen J, Gilmore EC, Marshall CA. , et al. Mutations in PNKP cause microcephaly, seizures and defects in DNA repair. Nat Genet 2010; 42 (03) 245-249
  • 3 Poulton C, Oegema R, Heijsman D. , et al. Progressive cerebellar atrophy and polyneuropathy: expanding the spectrum of PNKP mutations. Neurogenetics 2013; 14 (01) 43-51
  • 4 Taniguchi-Ikeda M, Morisada N, Inagaki H. , et al. Two patients with PNKP mutations presenting with microcephaly, seizure, and oculomotor apraxia. Clin Genet 2018; 93 (04) 931-933
  • 5 Pedroso JL, Rocha CR, Macedo-Souza LI. , et al. Mutation in PNKP presenting initially as axonal Charcot-Marie-Tooth disease. Neurol Genet 2015; 1 (04) e30
  • 6 Leal A, Bogantes-Ledezma S, Ekici AB. , et al. The polynucleotide kinase 3′-phosphatase gene (PNKP) is involved in Charcot-Marie-Tooth disease (CMT2B2) previously related to MED25. Neurogenetics 2018; 19 (04) 215-225
  • 7 Lozier ER, Konovalov FA, Kanivets IV. , et al. De novo nonsense mutation in WHSC1 (NSD2) in patient with intellectual disability and dysmorphic features. J Hum Genet 2018; 63 (08) 919-922
  • 8 Rudenskaya GE, Surkova EI, Konovalov FA. Ataxia with oculomotor apraxia type 4 detected by next-generation sequencing in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova 2018; 118 (03) 10-14
  • 9 Nair P, Hamzeh AR, Mohamed M. , et al. Microcephalic primordial dwarfism in an Emirati patient with PNKP mutation. Am J Med Genet A 2016; 170 (08) 2127-2132
  • 10 Entezam M, Razipour M, Talebi S, Beiraghi Toosi M, Keramatipour M. Multi affected pedigree with congenital microcephaly: WES revealed PNKP gene mutation. Brain Dev 2019; 41 (02) 182-186
  • 11 Paucar M, Malmgren H, Taylor M. , et al. Expanding the ataxia with oculomotor apraxia type 4 phenotype. Neurol Genet 2016; 2 (01) e49
  • 12 Tzoulis C, Sztromwasser P, Johansson S, Gjerde IO, Knappskog P, Bindoff LA. PNKP mutations identified by whole-exome sequencing in a Norwegian patient with sporadic ataxia and edema. Cerebellum 2017; 16 (01) 272-275
  • 13 Schiess N, Zee DS, Siddiqui KA, Szolics M, El-Hattab AW. Novel PNKP mutation in siblings with ataxia-oculomotor apraxia type 4. J Neurogenet 2017; 31 (1–2): 23-25
  • 14 Scholz C, Golas MM, Weber RG. , et al. Rare compound heterozygous variants in PNKP identified by whole exome sequencing in a German patient with ataxia-oculomotor apraxia 4 and pilocytic astrocytoma. Clin Genet 2018; 94 (01) 185-186
  • 15 Dumitrache LC, McKinnon PJ. Polynucleotide kinase-phosphatase (PNKP) mutations and neurologic disease. Mech Ageing Dev 2017; 161 (Pt. A): 121-129